menu
    • menu

    Company profile for Aurolife Pharma LLC

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aurolife is part of a group of companies that has a long history of excelling in generic pharmaceutical product development, manufacturing and marketing. The support and expertise of our parent organization has given Aurolife a jump start in building a solid pharmaceutical portfolio very quickly. The Aurolife family consists of an experienced management team with expertise in manufacturing, R&D, Quality Assurance and Quality c...
    Aurolife is part of a group of companies that has a long history of excelling in generic pharmaceutical product development, manufacturing and marketing. The support and expertise of our parent organization has given Aurolife a jump start in building a solid pharmaceutical portfolio very quickly. The Aurolife family consists of an experienced management team with expertise in manufacturing, R&D, Quality Assurance and Quality control, finance and regulatory affairs. Aurolife has 100,000 square feet state-of-the-art US FDA approved cGMP compliant manufacturing facility with an investment of over US $50 million.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aurolife Pharma LLCUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2400 US HWY 130 N Dayton, NJ 08810
    Telephone
    Telephone
    +1 732-839-9400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.aurolifepharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aurolife Pharma gets 11 observations from USFDA for Raleigh plant
    Aurolife Pharma gets 11 observations from USFDA for Raleigh plant

    14 Apr 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/drug-approval/aurolife-pharma-gets-11-observations-from-usfda-for-raleigh-plant-17022

    INDPHARMAPOST
    14 Apr 2025
    Share Share
    FDA Issues Form 483 to Aurolife Pharma
    FDA Issues Form 483 to Aurolife Pharma

    10 Apr 2025

    // FDA

    https://www.fda.gov/media/186635/download

    FDA
    10 Apr 2025
    Share Share
    Enforcement Report for Week of June 28, 2023
    Enforcement Report for Week of June 28, 2023

    28 Jun 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-june-28-2023-96236.pdf

    FDA
    28 Jun 2023
    Share Share
    Enforcement Report - Week of December 28, 2022
    Enforcement Report - Week of December 28, 2022

    28 Dec 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-28-2022-95999.pdf

    FDA
    28 Dec 2022
    Share Share
    Enforcement Report - Week of April 6, 2022
    Enforcement Report - Week of April 6, 2022

    06 Apr 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-6-2022-1649740823.pdf

    FDA
    06 Apr 2022
    Share Share
    Aurolife Pharma Receives FDA Warning Letter
    Aurolife Pharma Receives FDA Warning Letter

    25 Nov 2020

    // FDA

    https://www.pharmacompass.com/pdf/news/aurolife-pharma-receives-fda-warning-letter-1606284272.pdf

    FDA
    25 Nov 2020
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search